Deutsche Bank AG Acquires Shares of 121,326 National Health Investors, Inc. $NHI

Deutsche Bank AG acquired a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 121,326 shares of the real estate investment trust's stock, valued at approximately $9,252,000. Deutsche Bank AG owned about 0.25% of National Health Investors at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. NewEdge Advisors LLC raised its holdings in National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock valued at $114,000 after buying an additional 345 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust's stock worth $18,460,000 after buying an additional 21,851 shares during the last quarter. Jane Street Group LLC boosted its stake in National Health Investors by 1,728.4% during the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock worth $5,148,000 after buying an additional 65,885 shares during the period. Cetera Investment Advisers boosted its stake in National Health Investors by 6.1% during the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust's stock worth $336,000 after buying an additional 275 shares during the period. Finally, American Century Companies Inc. increased its position in National Health Investors by 2.2% during the second quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust's stock valued at $1,349,000 after acquiring an additional 420 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.

Insider Buying and Selling

In other news, Director Robert A. Mccabe, Jr. purchased 890 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares of the company's stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the company's stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the purchase, the chief executive officer owned 133,316 shares of the company's stock, valued at $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 2.70% of the company's stock.

National Health Investors Stock Performance

NHI stock opened at $73.59 on Monday. The firm has a market cap of $3.61 billion, a price-to-earnings ratio of 21.27, a PEG ratio of 3.36 and a beta of 0.51. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The business's fifty day simple moving average is $75.48 and its two-hundred day simple moving average is $79.09. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The company had revenue of $121.32 million during the quarter. The company's quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts predict that National Health Investors, Inc. will post 4.78 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.0%. National Health Investors's dividend payout ratio (DPR) is 108.67%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on NHI shares. Wells Fargo & Company reduced their target price on shares of National Health Investors from $84.00 to $79.00 and set an "equal weight" rating on the stock in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft dropped their price target on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a research note on Thursday, June 25th. Truist Financial cut their price target on shares of National Health Investors from $89.00 to $81.00 and set a "buy" rating on the stock in a report on Friday, June 12th. BMO Capital Markets reduced their price objective on shares of National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a research report on Monday, June 15th. Finally, Weiss Ratings downgraded shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research note on Friday, June 12th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $83.86.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source